About
Cell-Easy is a cell therapy CDMO in Toulouse, France. It supports academic laboratories, biotechs, and pharma companies with process development, analytical development, GMP cell banking, and GMP manufacturing for cell therapies.
Services
Cell Therapy Process Development & Scale-Up
Assesses, optimizes, and scales cell therapy processes to reduce variability and prepare them for GMP manufacturing.
Cell Therapy Analytical Development
Develops and transfers analytical methods for cell characterization, product quality assessment, and GMP quality control.
GMP Cell Banking Services (PCB/MCB/WCB)
Designs, generates, and maintains primary, master, and working cell banks under GMP and ICH Q5D/cGMP expectations.
Cell line development
Cell Therapy GMP Manufacturing
Transfers and manufactures clinical-grade cell therapy batches in a GMP facility, including technology transfer, engineering runs, and clinical batch production.
CDMO: development & manufacturing
Human Adipose-Derived Mesenchymal Stem Cells (Research Grade)
Provides cryopreserved human adipose-derived mesenchymal stem cells for laboratory and preclinical research.
Process & Development
Supports process development, optimization, scale-up, and transfer for cell therapy programs.
Cell line development
Analytical Development
Develops and qualifies analytical methods, product characterization assays, and GMP-quality-control transfers.
GMP Cell Banking
Provides GMP cell banking services for cell therapy development programs.
Cell line development
2 more services
- GMP Manufacturing
- Research-grade Human Adipose-Derived MSCs
- Turnaround
- 3 weeks to 3 months
- What to send
- Intended application
- Required quantity
- Delivery destination
- Quote requests should include intended application, required quantity, and delivery destination
Capabilities
- Assays and studies
- Cell therapy
- Analytical development
- Process development
- Stability studies
- Flow cytometry
- qPCR
13 more
- dPCR
- ELISA
- Ella-based assays
- Cell-based assays
- In vitro bioassays
- Immunocytochemistry (ICC)
- Colony-forming unit (CFU) assays
- Mixed lymphocyte reactions (MLR)
- Cell counting
- Endotoxin detection
- Stability assays
- Sterility testing
- Mycoplasma testing
- Scale and capacity
- 1000+ clinical doses manufactured in its GMP facility
- 15 cell types handled
- 50+ development programs
- 50+ processes developed
- 95% scale-up success rate
- 20+ GMP clinical batches released
7 more
- Five multi-suite Grade B cleanrooms
- Up to 40,000 viable doses from a single donor harvest
- Flexible batch sizes from 1 mL vials to 50 L lots
- Up to 500 pharmaceutical-grade vials
- 40,000 doses from a single donor
- >50 m² of new laboratory space
- Up to six members of the Development Department
- Therapeutic areas
- Cell therapy
- Crohn’s disease
- Complex anal fistulas
- Oncology
- Autoimmune diseases
- Regenerative medicine
Instruments and platforms
- Flow cytometry
- qPCR
- dPCR
- ELISA
- Ella
- Cell Stack
- G-Rex
- Cocoon
- CliniMACS
- Lovo
- G-Rex®
Modalities and species
- Modalities
- Cell therapy
- Species and models
- Human
- Single healthy donor
- Adipose tissue
- Stromal vascular fraction
- Cell Stack
- G-Rex
4 more
- Cocoon
- CliniMACS
- Lovo
- T-flasks
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
GMPSelf-reported
As listed: cGMP
Details
- Type
- CRDMO
- Based in
- Toulouse, France
- Sites
- Houston, United States
- Serves
- Europe, EU, US, global